Published in Am J Hum Genet on July 15, 2004
Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet (2007) 1.33
Replication stress and mechanisms of CNV formation. Curr Opin Genet Dev (2012) 1.23
Hydroxyurea induces de novo copy number variants in human cells. Proc Natl Acad Sci U S A (2011) 1.17
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol (2008) 1.12
Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet (2007) 1.10
A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn (2011) 1.08
Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06
Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood (2006) 1.05
The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. Neurogenetics (2009) 1.02
Detection and characterization of NF1 microdeletions by custom high resolution array CGH. J Mol Diagn (2009) 0.99
Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. J Med Genet (2012) 0.99
Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST. Am J Surg Pathol (2016) 0.99
Chromosome 22q11.2 microdeletion in monozygotic twins with discordant phenotype and deletion size. Mol Cytogenet (2012) 0.96
Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. Am J Hum Genet (2007) 0.94
Extensively high load of internal tumors determined by whole body MRI scanning in a patient with neurofibromatosis type 1 and a non-LCR-mediated 2-Mb deletion in 17q11.2. Hum Genet (2005) 0.94
Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. J Med Genet (2006) 0.93
Monozygotic twins discordant for neurofibromatosis 1. Am J Med Genet A (2010) 0.91
Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions. Neurogenetics (2012) 0.83
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints. Genome Biol (2014) 0.82
Population-specific differences in gene conversion patterns between human SUZ12 and SUZ12P are indicative of the dynamic nature of interparalog gene conversion. Hum Genet (2014) 0.78
Republished: Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. Postgrad Med J (2013) 0.77
Molecular and clinical analyses of 16q24.1 duplications involving FOXF1 identify an evolutionarily unstable large minisatellite. BMC Med Genet (2014) 0.77
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions. BMC Med Genet (2012) 0.76
126 novel mutations in Italian patients with neurofibromatosis type 1. Mol Genet Genomic Med (2015) 0.75
A novel de novo microdeletion at 17q11.2 adjacent to NF1 gene associated with developmental delay, short stature, microcephaly and dysmorphic features. Mol Cytogenet (2016) 0.75
Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet (2017) 0.75
Digital PCR for discriminating mosaic deletions and for determining proportion of tumor cells in specimen. Eur J Hum Genet (2016) 0.75
NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1. Am J Med Genet A (2010) 0.75
Segmental neurofibromatosis presenting with congenital excessive skin folds. Dermatol Pract Concept (2015) 0.75
Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports. J Med Case Rep (2011) 0.75
Genome architecture, rearrangements and genomic disorders. Trends Genet (2002) 12.26
Long-term potentiation--a decade of progress? Science (1999) 10.24
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet (2000) 6.21
Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet (2002) 4.51
Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet (2004) 4.47
Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat Genet (1997) 4.15
Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet (2003) 3.76
Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet (1994) 3.67
Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet (1999) 3.46
A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet (1996) 3.45
Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet (1992) 3.27
Translocation and gross deletion breakpoints in human inherited disease and cancer I: Nucleotide composition and recombination-associated motifs. Hum Mutat (2003) 2.55
Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A (2001) 2.54
Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am J Hum Genet (1998) 2.09
Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2. Am J Hum Genet (2003) 1.81
Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62
A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome--deletion region at 7q11.23. Am J Hum Genet (2000) 1.62
Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet (2001) 1.61
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet (1994) 1.56
Yeast ARMs (DNA at-risk motifs) can reveal sources of genome instability. Mutat Res (1998) 1.53
NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet (2000) 1.53
Unequal meiotic crossover: a frequent cause of NF1 microdeletions. Am J Hum Genet (2000) 1.40
Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations. Am J Med Genet (1995) 1.37
Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat (2004) 1.34
2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture. Am J Hum Genet (2003) 1.31
The amygdala and emotion. Curr Opin Neurobiol (1996) 1.30
Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science (1989) 1.24
Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet (1997) 1.23
An isochore transition in the NF1 gene region coincides with a switch in the extent of linkage disequilibrium. Am J Hum Genet (2000) 1.23
Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. Am J Med Genet (1997) 1.14
Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat (1999) 1.13
Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat (1997) 1.11
Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse. Genes Chromosomes Cancer (2003) 1.02
Deletion of the entire NF1 gene causing distinct manifestations in a family. Am J Med Genet (1997) 1.00
Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. Am J Hum Genet (2001) 0.99
Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet (1998) 0.97
Mitotic recombination mediated by the JJAZF1 (KIAA0160) gene causing somatic mosaicism and a new type of constitutional NF1 microdeletion in two children of a mosaic female with only few manifestations. J Med Genet (2003) 0.93
Translin binding to DNA: recruitment through DNA ends and consequent conformational transitions. Biochemistry (2002) 0.93
Recent developments in the diagnosis and management of neurofibromatosis. Arch Dis Child (1989) 0.92
A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions. Genomics (2000) 0.89
Long-term potentiation in mice lacking the neural cell adhesion molecule L1. Curr Biol (2001) 0.83
Excrement analysis by PCR. Nature (1992) 3.01
Induction of MHC class I genes in neurons. Science (1995) 2.84
Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity (2001) 2.77
Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc Natl Acad Sci U S A (1991) 1.91
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet (2008) 1.84
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
The effects of clinical case management on hospital service use among ED frequent users. Am J Emerg Med (2000) 1.75
Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet (2000) 1.71
The second case of a t(17;22) in a family with neurofibromatosis type 1: sequence analysis of the breakpoint regions. Hum Genet (1997) 1.54
The dup(3q) syndrome: report of eight cases and review of the literature. Am J Med Genet (1981) 1.52
Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1. J Med Genet (2005) 1.45
The opioid ketobemidone has a NMDA blocking effect. Pain (1996) 1.40
Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet (2000) 1.38
Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci U S A (1992) 1.38
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D). J Med Genet (2014) 1.36
Wegener's autoantigen decoded. Nature (1990) 1.31
Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc Natl Acad Sci U S A (1994) 1.30
Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety. AJR Am J Roentgenol (1995) 1.26
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet (2010) 1.23
Migration of human glioma cells on myelin. Neurosurgery (1996) 1.20
On the origin of the supernumerary chromosome in autosomal trisomies--with special reference to Down's syndrome. A bias in tracing nondisjunction by chromosomal and biochemical polymorphisms. Hum Genet (1976) 1.20
Free flap reconstruction of the head and neck: analysis of 241 cases. Otolaryngol Head Neck Surg (2001) 1.18
Structural variability of human chromosome 9 in relation to its evolution. Hum Genet (1976) 1.15
High resolution mapping of interstitial long arm deletions of chromosome 16: relationship to phenotype. J Med Genet (1993) 1.14
Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis (1998) 1.12
Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet (1999) 1.12
Cell specificity of granzyme gene expression. J Immunol (1990) 1.12
A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids (2000) 1.12
Molecular and cytogenetic analysis of an interstitial 20p deletion associated with syndromic intrahepatic ductular hypoplasia (Alagille syndrome). Hum Genet (1989) 1.10
Comparative maps of human 19p13.3 and mouse chromosome 10 allow identification of sequences at evolutionary breakpoints. Genome Res (2000) 1.10
The induction of non-disjunction by irradiation in mammalian oogenesis and spermatogenesis. Mutat Res (1979) 1.10
Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients. Genes Chromosomes Cancer (1999) 1.08
Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment. Fundam Appl Toxicol (1993) 1.08
Studies of pear-shaped nuclei using accelerated radioactive beams. Nature (2013) 1.08
RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference. Hum Mutat (2008) 1.07
Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet (2008) 1.06
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas. J Med Genet (2008) 1.06
Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20. J Biol Chem (1992) 1.05
20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet (2008) 1.04
CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice. Phytother Res (2009) 1.03
Child psychiatric diagnosis by computer algorithm: theoretical issues and empirical tests. J Am Acad Child Adolesc Psychiatry (1987) 1.02
Granzymes: a family of serine proteases in granules of cytolytic T lymphocytes. Curr Top Microbiol Immunol (1989) 1.01
Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD. Toxicol Appl Pharmacol (1996) 0.99
Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6. J Biol Chem (1989) 0.98
Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation. Ann Oncol (2010) 0.98
G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2. Genomics (1991) 0.97
Virtual genome scan: a tool for restriction landmark-based scanning of the human genome. Genome Res (2001) 0.97
Chromosome mapping of Rett syndrome: a likely candidate region on the telomere of Xq. J Med Genet (1998) 0.97
Screening methods for thyroid hormone disruptors. Environ Health Perspect (1999) 0.96
Color dynamics of the pupil. Ann N Y Acad Sci (1969) 0.95
The genetic significance of accessory bisatellited marker chromosomes. Hum Genet (1983) 0.95
Maternal UPD 20 in a hyperactive child with severe growth retardation. Eur J Hum Genet (1999) 0.94
Parental mosaicism of JAG1 mutations in families with Alagille syndrome. Eur J Hum Genet (2001) 0.94
MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology (2006) 0.94
Cleavage of La protein by granzyme H induces cytoplasmic translocation and interferes with La-mediated HCV-IRES translational activity. Cell Death Differ (2008) 0.94
Mitotic recombination mediated by the JJAZF1 (KIAA0160) gene causing somatic mosaicism and a new type of constitutional NF1 microdeletion in two children of a mosaic female with only few manifestations. J Med Genet (2003) 0.93
Cytogenic investigation of 103 patients with primary or secondary amenorrhea. Hum Genet (1983) 0.93
Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma. Acta Neuropathol (1998) 0.93
Induced chromosome aberrations in unfertilized oocytes of mice. Humangenetik (1971) 0.93
Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis? Br J Dermatol (2003) 0.92
Changes in chromatin organization at the neutrophil elastase locus associated with myeloid cell differentiation. Blood (1999) 0.92
Partial trisomy 7q in two siblings. Ann Genet (1983) 0.92
Familial Prader-Willi syndrome with apparently normal chromosomes. Am J Med Genet (1987) 0.91
Construction of a detailed physical and transcript map of the candidate region for Russell-Silver syndrome on chromosome 17q23-q24. Genomics (2001) 0.91
Molecular characterization and application of random amplified polymorphic DNA analysis of Mrakia and Sterigmatomyces species. Int J Syst Bacteriol (1994) 0.90
Allelic losses in neurofibromatosis 2-associated meningiomas. J Neuropathol Exp Neurol (2000) 0.90
Supporting evidence of a gene for partial epilepsy on 10q. Neurogenetics (2000) 0.90
A cytogenetic study directly from chorionic villi of 140 spontaneous abortions. Hum Genet (1987) 0.90
The rate of homozygous CDKN2A/p16 deletions in glioma cell lines and in primary tumors. Int J Oncol (1999) 0.89
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet (2006) 0.89
Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis. Neurogenetics (1999) 0.89
Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer (2001) 0.89
A genetic map of chromosome 20q12-q13.1: multiple highly polymorphic microsatellite and RFLP markers linked to the maturity-onset diabetes of the young (MODY) locus. Am J Hum Genet (1993) 0.89
Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma. J Biol Chem (1999) 0.89
Kabuki syndrome-like features associated with a small ring chromosome X and XIST gene expression. Am J Med Genet (2001) 0.88
Anorexia nervosa: towards an integrative neuroscience model. Eur Eat Disord Rev (2010) 0.88
Crossing-over during human spermatogenesis visualized cytologically. Hum Genet (1982) 0.88
Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients. Anticancer Res (2003) 0.87
Human clusterin (CLI) maps to 8p21 in proximity to the lipoprotein lipase (LPL) gene. Genomics (1993) 0.87
Development of an instrument to assess readiness to recover in anorexia nervosa. Int J Eat Disord (2000) 0.87
The human Met-ase gene (GZMM): structure, sequence, and close physical linkage to the serine protease gene cluster on 19p13.3. Genomics (1994) 0.87
Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer (1996) 0.87
Skin abnormalities in neurofibromatosis 2. Arch Dermatol (1997) 0.86
Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into alpha-granules. Blood (1993) 0.86
NF1 mutations and clinical spectrum in patients with spinal neurofibromas. J Med Genet (2003) 0.86
Therapy of brown spider envenomation: a controlled trial of hyperbaric oxygen, dapsone, and cyproheptadine. Ann Emerg Med (1995) 0.86
Chromosome aberrations in metaphase II-oocytes. Stage sensitivity in the mouse oogenesis to amethopterin and cyclophosphamide. Mutat Res (1974) 0.86
The human dead ringer/bright homolog, DRIL1: cDNA cloning, gene structure, and mapping to D19S886, a marker on 19p13.3 that is strictly linked to the Peutz-Jeghers syndrome. Genomics (1998) 0.86
The gene for bone morphogenetic protein 2A (BMP2A) is localized to human chromosome 20p12 by radioactive and nonradioactive in situ hybridization. Hum Genet (1992) 0.86
Silver-Russell syndrome and cystic fibrosis associated with maternal uniparental disomy 7. Am J Med Genet (2000) 0.86
Induced chromosome aberrations in early embryogenesis of mice. Humangenetik (1971) 0.85
Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region. J Med Genet (2003) 0.85
Localization of Alagille syndrome to 20p11.2-p12 by linkage analysis of a three-generation family. Hum Genet (1995) 0.85
Phenotypic findings due to trisomy 7p15.3-pter including the TWIST locus. Am J Med Genet (2001) 0.85
The child as a determinant of his peers' approach to him. J Genet Psychol (1966) 0.85
Structural and functional characterization of complement C8 gamma, a member of the lipocalin protein family. Mol Immunol (1991) 0.85
Repeated measurements of allergens and endotoxin in settled house dust over a time period of 6 years. Clin Exp Allergy (2003) 0.85